Related Experiment Video
Updated: Sep 24, 2025
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.9K
Senhance robot-assisted adrenalectomy: a case series
Nikola Knežević, Luka Penezić1, Tomislav Kuliš
1Luka Penezić, Kišpatićeva 12, 10000 Zagreb, Croatia, penezic.luka@gmail.com.
Croatian Medical Journal
|May 4, 2022
Summary
Robot-assisted adrenalectomy using the Senhance system is safe and effective for benign adrenal conditions. This case series shows successful outcomes, including biochemical remission for primary aldosteronism.
Area of Science:
- Minimally Invasive Surgery
- Robotic Surgery
- Endocrine Surgery
Background:
- Robot-assisted adrenalectomy is an emerging technique for adrenal gland surgery.
- The Senhance robotic system offers advanced features for complex procedures.
- Evaluating the feasibility and outcomes of robotic adrenalectomy is crucial.
Observation:
- A case series of 12 robot-assisted adrenalectomies using the Senhance system was performed.
- Patients presented with primary aldosteronism (n=11) or adrenal cysts (n=1).
- The surgical technique and system performance were detailed.
Findings:
- Mean procedure time was 165.1 minutes, with a mean console time of 98.6 minutes.
- Mean estimated blood loss was 47 mL, and mean hospital stay was 4.5 days.
- One Clavien Dindo IIIB complication and one conversion to laparoscopy occurred; all adenoma patients achieved biochemical remission.
Implications:
- The Senhance robotic system demonstrates safety and feasibility for benign adrenal surgery.
- High-volume centers can consider this platform for adrenalectomies.
- Further studies are warranted to confirm long-term outcomes and expand indications.
